<DOC>
	<DOCNO>NCT01863576</DOCNO>
	<brief_summary>The objective trial study effect omega-3 PUFA supplementation inflammatory response lipid profile patient chronic Chagas cardiomyopathy . Study Type : Interventional Study Design : A total 40 patient randomly assign two parallel group . The intervention treatment omega-3 PUFAs dose 3 g/day 8 week , compare placebo ( corn oil ) . The primary endpoint concentration inflammatory marker ( IL-1 , IL-2 , IL-4 , IL-6 , IL-10 , TNF-alpha , IFN-γ , TGF-β ) . Secondary endpoint fast glucose , lipid , anthropometric profile .</brief_summary>
	<brief_title>Effects Omega-3 Supplementation Cytokine Lipid Profiles Patients With Chronic Chagas Cardiomyopathy</brief_title>
	<detailed_description>Several study show beneficial effect polyunsaturated fatty acid inflammatory process , dyslipidemia , cardiovascular disease , report food intake PUFA supplementation chronic Chagas cardiomyopathy patient . Thus , objective study assess effect omega-3 PUFA supplementation lipid profile pro-inflammatory anti-inflammatory cytokine profile chronic Chagas cardiomyopathy patient . After patient selected cardiologist , see study nutritionist , explain study procedure patient administer free inform consent form . The patient agree participate study sign consent form undergo initial assessment . The following data collect evaluated study : sociodemographic data ( age , sex , ethnicity/race , education , domicile ) , clinical data ( functional class vital sign ) , alcoholism , smoking , prescription drug , 3-day food record , 24-hour recall , anthropometric assessment ( height , weight , BMI , waist circumference , tricipital skinfold thickness , arm circumference ) , lipid profile ( total cholesterol , triglyceride , HDL-c , LDL-c , VLDL-c ) , cytokine ( IL-1 , IL-2 , IL-4 , IL-6 , IL-10 , TNF-alpha , IFN-γ , TGF-β ) . Clinical , nutritional , anthropometric assessment take place immediately start intervention 4 8 week study ; lipid profile cytokine evaluate intervention end 8 week . Each patient follow 8 week .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Chagas Cardiomyopathy</mesh_term>
	<criteria>Volunteers Chagas Cardiomyopathy stage B ( heart failure symptom segmental global leave ventricular systolic dysfunction ) , stage C ( symptomatic heart failure ) , stage D ( endstage heart failure ) ) , accord current Brazilian Chagas ' Disease Consensus ; Subjects include adult , men woman . diarrheal disease ; inflammatory bowel syndrome ; diagnosis diabetes endocrine pathology ; use fibrates , niacin , statin ; use antiinflammatory drug ; pregnant lactating woman ; vitamin mineral omega3 supplementation previous 30 day ; hospital admission study ; presence cardiomyopathy Chagas Cardiomyopathy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Chagas disease</keyword>
	<keyword>Chagas Cardiomyopathy</keyword>
	<keyword>Trypanosoma cruzi</keyword>
	<keyword>Omega-3</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Lipid profile</keyword>
	<keyword>Nutritional assessment</keyword>
</DOC>